Sven Olek
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis.
Journal: Frontiers in immunology
Published: June 19, 2024
Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations.
Journal: Science translational medicine
Published: December 20, 2023
Specifications of qPCR based epigenetic immune cell quantification.
Journal: Clinical chemistry and laboratory medicine
Published: September 25, 2023
Epigenetic immune cell quantification for diagnostic evaluation and monitoring of patients with inborn errors of immunity and secondary immune deficiencies.
Journal: Clinical immunology (Orlando, Fla.)
Published: June 08, 2023
Epigenetic immune monitoring for COVID-19 disease course prognosis.
Journal: Frontiers in immunology
Published: November 25, 2022
FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome.
Journal: Journal of clinical immunology
Published: July 12, 2022
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation.
Journal: The Journal of allergy and clinical immunology
Published: April 28, 2022
Urinary CD8+HLA-DR+ T Cell Abundance Non-invasively Predicts Kidney Transplant Rejection.
Journal: Frontiers in medicine
Published: April 25, 2022
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set.
Journal: Current research in translational medicine
Published: September 29, 2021
Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre study.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: June 25, 2021
Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 09, 2021
Last Updated: 09/26/2026